Skip to main content

Gene Therapy of Salivary Diseases

  • Protocol
  • First Online:
Oral Biology

Abstract

For many years, our research group worked to develop gene transfer approaches for salivary gland disorders that lacked effective conventional therapy. The purpose of this chapter is to describe and update key methods used in this process. As described in our original chapter from the 2010 volume, we focus on one clinical condition, irradiation-induced salivary hypofunction, and address the choice of transgene and vector to be used, the construction of recombinant viral vectors, how vector delivery is accomplished, and methods for assessing vector function in vitro and in an appropriate animal model.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics 2015 CA. Cancer J Clin 65:5–29

    Article  Google Scholar 

  2. Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM (2006) Sjögren’s syndrome: why autoimmune epithelitis. Oral Dis 12:523–532

    Article  CAS  PubMed  Google Scholar 

  3. Kok MR, Yamano S, Lodde BM, Wang J, Couwenhoven RI, Yakar S, Voutetakis A, Leroith D, Schmidt M, Afione S, Pillemer SR, Tsutsui MT, Tak PP, Chiorini JA, Baum BJ (2003) Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren’s syndrome. Hum Gene Ther 14:1605–1618

    Article  CAS  PubMed  Google Scholar 

  4. Baum BJ (1993) Principles of saliva secretion. Ann NY Acad Sci 694:17–23

    Article  CAS  PubMed  Google Scholar 

  5. Vitolo JM, Baum BJ (2002) The use of gene transfer for the protection and repair of salivary glands. Oral Dis 8:183–191

    Article  CAS  PubMed  Google Scholar 

  6. Preston GM, Agre P (1991) Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc Natl Acad Sci U S A 88:11110–11114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Baum BJ, Wellner RB, Zheng C (2002) Gene transfer to salivary glands. Int Rev Cytol 213:93–146

    Article  CAS  PubMed  Google Scholar 

  8. Mastrangeli A, O'Connell B, Aladib W, Fox PC, Baum BJ, Crystal RG (1994) Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am J Physiol 266:G1146–G1155

    CAS  PubMed  Google Scholar 

  9. McGrory WJ, Bautista DS, Graham FL (1988) A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163:614–617

    Article  CAS  PubMed  Google Scholar 

  10. Graham FL, Smiley J, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74

    Article  CAS  PubMed  Google Scholar 

  11. Chiorini JA, Wendtner CM, Urcelay E, Safer B, Hallek M, Kotin RM (1995) High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther 6:1531–1541

    Article  CAS  PubMed  Google Scholar 

  12. Park JY, Lim BP, Lee K, Kim YG, Jo EC (2006) Scalable production of adeno- associated virus type 2 vectors via suspension transfection. Biotechnol Bioeng 94:416–430

    Article  CAS  PubMed  Google Scholar 

  13. Qu G, McClelland A, Wright JF (2000) Scaling-up production of recombinant AAV vectors for clinical applications. Curr Opin Drug Discov Devel 3:750–755

    CAS  PubMed  Google Scholar 

  14. Clark KR, Voulgaropoulou F, Johnson PR (1996) A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther 3:1124–1132

    CAS  PubMed  Google Scholar 

  15. Conway JE, Rhys CM, Zolotukhin I, Zolotukhin S, Muzyczka N, Hayward GS, Byrne BJ (1999) High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther 6:986–993

    Article  CAS  PubMed  Google Scholar 

  16. Gao GP, Lu F, Sanmiguel JC, Tran PT, Abbas Z, Lynd KS, Marsh J, Spinner NB, Wilson JM (2002) Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap. Mol Ther 5:644–649

    Article  CAS  PubMed  Google Scholar 

  17. Urabe M, Ding C, Kotin RM (2002) Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Sene Ther 13:1935–1943

    Article  CAS  Google Scholar 

  18. Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, Mitchell JB, Baum BJ (2004) The stable nitroxide Tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res 10:1807–1812

    Article  CAS  PubMed  Google Scholar 

  19. Cotrim AP, Hyodo F, Matsumoto K, Sowers AL, Cook JA, Baum BJ, Krishna MC, Mitchell JB (2007) Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res 13:4928–4933

    Article  CAS  PubMed  Google Scholar 

  20. Walters RW, Yi SM, Keshavjee S, Brown KE, Welsh MJ, Chiorini JA, Zabner J (2001) Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 273:20610–20616

    Article  Google Scholar 

  21. Smith RH, Afione S, Kotin RM (2002) Transposase-mediated construction of an integrated adeno associated virus type 5 helper plasmid. Biotechniques 208:210–211

    Google Scholar 

Download references

Acknowledgment

The authors’ research is supported by the intramural research program of the National Institute of Dental and Craniofacial Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bruce J. Baum M.P.T.B., N.I.D.C.R., N.I.H. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Baum, B.J., Afione, S., Chiorini, J.A., Cotrim, A.P., Goldsmith, C.M., Zheng, C. (2017). Gene Therapy of Salivary Diseases. In: Seymour, G., Cullinan, M., Heng, N. (eds) Oral Biology. Methods in Molecular Biology, vol 1537. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6685-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6685-1_6

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6683-7

  • Online ISBN: 978-1-4939-6685-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics